MGNX
Macrogenics·NASDAQ
--
--(--)
--
--(--)
MGNX fundamentals
Macrogenics (MGNX) released its earnings on Aug 14, 2025: revenue was 22.24M (YoY +105.99%), missed estimates; EPS was -0.57 (YoY +35.96%), missed estimates.
Revenue / YoY
22.24M
+105.99%
EPS / YoY
-0.57
+35.96%
Report date
Aug 14, 2025
Earnings Call
7:00 AM on Aug 14, 2025
Meeting link.Earnings
EPS
Revenue
Revenue & Expenses
MGNX has released its 2025 Q4 earnings report, with revenue of 41.23M, reflecting a YoY change of 113.03%, and net profit of -14.15M, showing a YoY change of 8.21%. The Sankey diagram below clearly presents MGNX's revenue sources and cost distribution.
Key Indicators
Macrogenics (MGNX) key financial stats and ratios, covering profitability, financial health, and leverage.
Income Statement
Macrogenics (MGNX)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Balance Sheet
Macrogenics (MGNX)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Cash Flow
Macrogenics (MGNX)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Revenue Breakdown
Where does Macrogenics (MGNX) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Dividend
Track Macrogenics (MGNX) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is the revenue and EPS growth rate for Macrogenics year over year?Did Macrogenics beat or miss consensus estimates last quarter?What does Macrogenics do and what are its main business segments?What is the market's earnings forecast for Macrogenics next quarter?What is Macrogenics's gross profit margin?What were the key takeaways from Macrogenics's earnings call?What factors drove the changes in Macrogenics's revenue and profit?What guidance did Macrogenics's management provide for the next earnings period?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
